US Pharma MarketingEyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
Kyverna Therapeutics is on the cusp of a historic first: getting a CAR-T therapy approved for an autoimmune disease—and now it’s looking to boost its commercial chops as it nears the finish line.
Kyverna Therapeutics is on the cusp of a historic first: getting a CAR-T therapy approved for an autoimmune disease—and now it’s looking to boost its commercial chops as it nears the finish line.
Source: FiercePharma